These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

581 related items for PubMed ID: 26233438

  • 1. Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer's disease.
    Shimizu S, Hirao K, Kanetaka H, Namioka N, Hatanaka H, Hirose D, Fukasawa R, Umahara T, Sakurai H, Hanyu H.
    Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):184-192. PubMed ID: 26233438
    [Abstract] [Full Text] [Related]

  • 2. (123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography and (123) I-metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A comparative study.
    Tiraboschi P, Corso A, Guerra UP, Nobili F, Piccardo A, Calcagni ML, Volterrani D, Cecchin D, Tettamanti M, Antelmi L, Vidale S, Sacco L, Merello M, Stefanini S, Micheli A, Vai P, Capitanio S, Gabanelli SV, Riva R, Pinto P, Biffi AM, Muscio C, SCILLA Working Group.
    Ann Neurol; 2016 Sep; 80(3):368-78. PubMed ID: 27398636
    [Abstract] [Full Text] [Related]

  • 3. The usefulness of combined brain perfusion single-photon emission computed tomography, Dopamine-transporter single-photon emission computed tomography, and 123 I-metaiodobenzylguanidine myocardial scintigraphy for the diagnosis of dementia with Lewy bodies.
    Kobayashi S, Makino K, Hatakeyama S, Ishii T, Tateno M, Iwamoto T, Tsujino H, Kawasaki K, Mikuni K, Ukai W, Murayama T, Hashimoto E, Utsumi K, Kawanishi C.
    Psychogeriatrics; 2017 Jul; 17(4):247-255. PubMed ID: 28130808
    [Abstract] [Full Text] [Related]

  • 4. A diagnostic strategy for Lewy body disease using DAT-SPECT, MIBG and Combined index.
    Sakamoto F, Shiraishi S, Ogasawara K, Tsuda N, Nakagawa M, Tomiguchi S, Yamashita Y.
    Ann Nucl Med; 2020 Jun; 34(6):415-423. PubMed ID: 32301068
    [Abstract] [Full Text] [Related]

  • 5. The utility of the combination of a SPECT study with [123I]-FP-CIT of dopamine transporters and [123I]-MIBG myocardial scintigraphy in differentiating Parkinson disease from other degenerative parkinsonian syndromes.
    Uyama N, Otsuka H, Shinya T, Otomi Y, Harada M, Sako W, Izumi Y, Kaji R, Watanabe Y, Takashi S, Kunikane Y.
    Nucl Med Commun; 2017 Jun; 38(6):487-492. PubMed ID: 28410288
    [Abstract] [Full Text] [Related]

  • 6. Diagnostic Sensitivity and Symptomatic Relevance of Dopamine Transporter Imaging and Myocardial Sympathetic Scintigraphy in Patients with Dementia with Lewy Bodies.
    Tang Z, Hirano S, Koizumi Y, Izumi M, Kitayama Y, Yamagishi K, Tamura M, Ishikawa A, Kashiwado K, Iimori T, Mukai H, Yokota H, Horikoshi T, Uno T, Kuwabara S.
    J Alzheimers Dis; 2024 Jun; 100(1):127-137. PubMed ID: 38848178
    [Abstract] [Full Text] [Related]

  • 7. Comparative value of brain perfusion SPECT and [(123)I]MIBG myocardial scintigraphy in distinguishing between dementia with Lewy bodies and Alzheimer's disease.
    Hanyu H, Shimizu S, Hirao K, Kanetaka H, Iwamoto T, Chikamori T, Usui Y, Yamashina A, Koizumi K, Abe K.
    Eur J Nucl Med Mol Imaging; 2006 Mar; 33(3):248-53. PubMed ID: 16328506
    [Abstract] [Full Text] [Related]

  • 8. Neuroimaging for diagnosing dementia with Lewy bodies: What is the best neuroimaging technique in discriminating dementia with Lewy bodies from Alzheimer's disease?
    Shimizu S, Kanetaka H, Hirao K, Fukasawa R, Namioka N, Hatanaka H, Hirose D, Umahara T, Sakurai H, Hanyu H.
    Geriatr Gerontol Int; 2017 May; 17(5):819-824. PubMed ID: 27138074
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of (123)I-MIBG myocardial scintigraphy, brain perfusion SPECT, and voxel-based MRI morphometry for distinguishing between dementia with Lewy bodies and Alzheimer's disease.
    Inui Y, Toyama H, Manabe Y, Sarai M, Iwata N.
    Ann Nucl Med; 2014 Oct; 28(8):796-804. PubMed ID: 24986482
    [Abstract] [Full Text] [Related]

  • 11. 123I-MIBG scintigraphy utility and cut-off value in a clinically representative dementia cohort.
    Kane JPM, Roberts G, Petrides GS, Lloyd JJ, O'Brien JT, Thomas AJ.
    Parkinsonism Relat Disord; 2019 May; 62():79-84. PubMed ID: 30709778
    [Abstract] [Full Text] [Related]

  • 12. Dopamine transporter imaging for the diagnosis of dementia with Lewy bodies.
    McCleery J, Morgan S, Bradley KM, Noel-Storr AH, Ansorge O, Hyde C.
    Cochrane Database Syst Rev; 2015 Jan 30; 1(1):CD010633. PubMed ID: 25632881
    [Abstract] [Full Text] [Related]

  • 13. Serotonergic deficits in dementia with Lewy bodies with concomitant Alzheimer's disease pathology: An 123I-FP-CIT SPECT study.
    van der Zande JJ, Joling M, Happach IG, Vriend C, Scheltens P, Booij J, Lemstra AW.
    Neuroimage Clin; 2020 Jan 30; 25():102062. PubMed ID: 31790878
    [Abstract] [Full Text] [Related]

  • 14. Usefulness of [123I]metaiodobenzylguanidine ([123I]MIBG) myocardial scintigraphy in differentiating between Alzheimer's disease and dementia with Lewy bodies.
    Oide T, Tokuda T, Momose M, Oguchi K, Nakamura A, Ohara S, Ikeda S.
    Intern Med; 2003 Aug 30; 42(8):686-90. PubMed ID: 12924492
    [Abstract] [Full Text] [Related]

  • 15. 123I-MIBG myocardial scintigraphy for the diagnosis of DLB: a multicentre 3-year follow-up study.
    Komatsu J, Samuraki M, Nakajima K, Arai H, Arai H, Arai T, Asada T, Fujishiro H, Hanyu H, Iizuka O, Iseki E, Kashihara K, Kosaka K, Maruno H, Mizukami K, Mizuno Y, Mori E, Nakamura H, Nakano S, Nakashima K, Nishio Y, Orimo S, Takahashi A, Taki J, Tokuda T, Urakami K, Utsumi K, Wada K, Washimi Y, Yamashina S, Yamasaki J, Yoshita M, Yamada M.
    J Neurol Neurosurg Psychiatry; 2018 Nov 30; 89(11):1167-1173. PubMed ID: 29853532
    [Abstract] [Full Text] [Related]

  • 16. Combined use of dopamine transporter imaging (DAT-SPECT) and 123I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy for diagnosing Parkinson's disease.
    Yoshii F, Ryo M, Baba Y, Koide T, Hashimoto J.
    J Neurol Sci; 2017 Apr 15; 375():80-85. PubMed ID: 28320195
    [Abstract] [Full Text] [Related]

  • 17. A comparison of 99mTc-exametazime and 123I-FP-CIT SPECT imaging in the differential diagnosis of Alzheimer's disease and dementia with Lewy bodies.
    Colloby SJ, Firbank MJ, Pakrasi S, Lloyd JJ, Driver I, McKeith IG, Williams ED, O'Brien JT.
    Int Psychogeriatr; 2008 Dec 15; 20(6):1124-40. PubMed ID: 18752700
    [Abstract] [Full Text] [Related]

  • 18. Differentiation of frontotemporal dementia from dementia with Lewy bodies using FP-CIT SPECT.
    Morgan S, Kemp P, Booij J, Costa DC, Padayachee S, Lee L, Barber C, Carter J, Walker Z.
    J Neurol Neurosurg Psychiatry; 2012 Nov 15; 83(11):1063-70. PubMed ID: 22869921
    [Abstract] [Full Text] [Related]

  • 19. Comparison of diagnostic utility of semi-quantitative analysis for DAT-SPECT for distinguishing DLB from AD.
    Shimizu S, Namioka N, Hirose D, Kanetaka H, Hirao K, Hatanaka H, Takenoshita N, Kaneko Y, Ogawa Y, Tsugawa A, Umahara T, Sakurai H, Hanyu H.
    J Neurol Sci; 2017 Jun 15; 377():50-54. PubMed ID: 28477707
    [Abstract] [Full Text] [Related]

  • 20. 123I-metaiodobenzylguanidine myocardial scintigraphy with early images alone is useful for the differential diagnosis of dementia with Lewy bodies.
    Manabe Y, Inui Y, Toyama H, Kosaka K.
    Psychiatry Res Neuroimaging; 2017 Mar 30; 261():75-79. PubMed ID: 28152401
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.